From depressive symptoms to depression in people with epilepsy: Contribution of physical exercise to improve this picture

4. Do AEDs contribute to depressive symp

4. Do AEDs contribute to depressive symptoms and suicidal ideation in people with epilepsy?

✍ Marco Mula 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Increased ratio of glutamate/glutamine t

Increased ratio of glutamate/glutamine to creatine in the right hippocampus contributes to depressive symptoms in patients with epilepsy

✍ Peng, Wei-Feng; Ding, Jing; Mao, Ling-Yan; Li, Xin; Liang, Liang; Chen, Cai-Zhon 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 314 KB

The use of the NDDI-E in Arabic to ident

The use of the NDDI-E in Arabic to identify symptoms of depression of moderate or greater severity in people with epilepsy

✍ Alkhamees, Hadeel A.; Selai, Caroline E.; Shorvon, Simon D.; Kanner, Andres M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Can Counseling and Support Reduce Burden

Can Counseling and Support Reduce Burden and Depressive Symptoms in Caregivers of People with Alzheimer's Disease During the Transition to Institutionalization? Results from the New York University Caregiver Intervention Study

✍ Joseph E. Gaugler; David L. Roth; William E. Haley; Mary S. Mittelman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Can Counseling and Support Reduce Burden

Can Counseling and Support Reduce Burden and Depressive Symptoms in Caregivers of People with Alzheimer's Disease During the Transition to Institutionalization? Results from the New York University Caregiver Intervention Study

✍ Joseph E. Gaugler; David L. Roth; William E. Haley; Mary S. Mittelman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

**OBJECTIVES:** To determine whether counseling and support reduce the burden and depressive symptoms of spouse caregivers of patients with Alzheimer's disease (AD) during the transition to institutionalization. **DESIGN:** A randomized, controlled trial of an enhanced counseling and support prog

Ustekinumab significantly improves sympt

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial

✍ Richard G. Langley; Steven R. Feldman; Chenglong Han; Brad Schenkel; Philippe Sz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 415 KB